Screener
Evolus EOLS Product revenue, net — Total net revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Evolus in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Evolus’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:56 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053468
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue: | ||||
| Product revenue, net | $83,350 | $68,699 | $156,097 | $136,773 |
| Service revenue | 734 | 688 | 1,124 | 1,136 |
| Total net revenues | 84,084 | 69,387 | 157,221 | 137,909 |
| Cost of goods sold | 26,904 | 24,067 | 51,144 | 45,934 |
| Gross profit | 57,180 | 45,320 | 106,077 | 91,975 |
| Operating expenses: | ||||
| Selling, general and administrative | 57,052 | 56,675 | 109,033 | 113,315 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Evolus's product revenue, net — total net revenues?
- Evolus (EOLS) reported product revenue, net — total net revenues of $83.35M in Q2 2026.
- How has Evolus's product revenue, net — total net revenues changed year-over-year?
- Evolus's product revenue, net — total net revenues increased by 21.3% year-over-year, from $68.7M to $83.35M.
- What is the long-term trend for Evolus's product revenue, net — total net revenues?
- Over 4 years (2021 to 2025), Evolus's product revenue, net — total net revenues has grown at a 31.4% compound annual growth rate (CAGR), from $98.97M to $294.96M.
- What does product revenue, net — total net revenues mean?
- This metric represents the total net revenue generated from the sale of the company's primary aesthetic pharmaceutical products after accounting for returns, allowances, and discounts. It serves as a key indicator of market adoption and commercial performance within the self-pay aesthetic medical market. Growth in this segment reflects the company's ability to expand its customer base and increase product penetration in the competitive neurotoxin landscape.
Ask your AI about Evolus's product revenue, net — total net revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude